ラベタロルの血液動力学的効果の遡及的再評価
Mary Margaret Rinker1, Teresa Valadez1,2, Renee Petzel Gimbar1,2
1Department of Pharmacy Practice, University of Illinois at Chicago, Retzky College of Pharmacy, Chicago, IL, USA.
Journal of pharmacy practice
|August 23, 2025
まとめ
静脈内投与 ラベタロール
科学分野:
- 薬理学について
- 心血管医学
- 臨床薬局
背景:
- ラベタロールは通常,血圧管理に使用されるアドレナergic 反抗剤です.
- 現在の薬剤の参考文献では,静脈内注射されたラベタロールのアルファとベータの効能比は1: 7であり,主に負の心力向上の効果を示唆しています.
- 報告されたこの比率は,臨床実務での観察と相違しています.
研究 の 目的:
- 静脈内 (IV) ラベタロールの実際の血液動力学的効果を記述する.
- 観察された血液動力学的効果と,公式の薬剤参照で記録されたものを比較する.
- IVラベタロールの臨床的アルファとベータの効能比を調査する.
主な方法:
- 遡及的観察コホート研究
- 急性不全性脳卒中のためにIVラベタロールを投与する患者も含まれていた.
- 投与後1時間以内の心拍数変化で割ったシストリック血圧 (SBP) の変化として計算された相対臨床効能 (RCP).
主要な成果:
- 平均年齢66歳,女性71%
- ラベタロルの中位投与量は,中位 ΔSBP が - 35 mmHg と ΔHR が - 9 bpm であった.
- 観察されたアルファとベータのRCPは約7:2で,参照の1: 7の比率とは著しく異なる.
- 10人の患者は,SBPの過度の低下を経験し,新しいブラディカルディアまたは反射性短心症は観察されなかった.
結論:
- 臨床観察は,IVラベタロールのアルファとベータの効能比が7:2であることを示し,公式の参照と矛盾している (1: 7).
- 発見は,現実世界の臨床経験と既存の薬物情報との間の不一致を示唆しています.
- IVラベタロールの臨床使用をよりよく導くために,公式の参考文献を更新することを推奨する.
関連する概念動画
Adrenergic Antagonists: ɑ and β-Receptor Blockers
591
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
591
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
844
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
844
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
966
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
966
Heart Failure Drugs: β-Blockers
434
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
434
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Measurement of Blood Pressure
1.4K
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a...
1.4K


